Home/Filings/4/0000899243-20-032454
4//SEC Filing

Wegman Mark N 4

Accession 0000899243-20-032454

CIK 0000875622other

Filed

Dec 1, 7:00 PM ET

Accepted

Dec 2, 9:46 AM ET

Size

11.0 KB

Accession

0000899243-20-032454

Insider Transaction Report

Form 4
Period: 2020-12-02
Transactions
  • Disposition to Issuer

    Common Stock, $0.001 par value

    2020-12-0264,7621,726 total
  • Gift

    Common Stock, $0.001 par value

    2020-11-172,40066,488 total
  • Disposition to Issuer

    Common Stock, $0.001 par value

    2020-12-021,7260 total
  • Disposition to Issuer

    Common Stock, $0.001 par value

    2020-12-02935,0730 total(indirect: See footnote)
Footnotes (5)
  • [F1]On November 17, 2020, the reporting person transferred 2,400 shares of common stock to a charitable fund.
  • [F2]Upon the consummation of the merger (the "Merger") contemplated by that certain Agreement and Plan of Merger, by and among BioSpecifics Technologies Corp., Endo International plc, and Beta Acquisition Corp., dated October 19, 2020 (the "Merger Agreement"), 64,762 shares of common stock were exchanged for a cash payment of $5,731,437, representing the product obtained by multiplying the offer price ($88.50) by the number of shares owned by the reporting person.
  • [F3]Upon the consummation of the Merger, pursuant to the Merger Agreement, 1,726 outstanding restricted stock units ("RSUs") were cancelled in exchange for a cash payment of $152,751.00, representing the product obtained by multiplying (x) the aggregate number of shares of common stock underlying the RSUs, by (y) the offer price ($88.50).
  • [F4]Upon the consummation of the Merger, 935,073 shares of common stock held by the MARITAL TRUST U/W/O EDWIN H WEGMAN DATED 08/10/06 (the "Trust") were exchanged for a cash payment of $82,753,960.50, representing the product obtained by multiplying the offer price ($88.50) by the number of shares owned by the Trust.
  • [F5]These shares are held in trust on behalf of the reporting person. The reporting person is the co-trustee of the Trust. The reporting person disclaims beneficial ownership of the shares held by the Trust except to the extent of the reporting person's pecuniary interest therein.

Issuer

BIOSPECIFICS TECHNOLOGIES CORP

CIK 0000875622

Entity typeother

Related Parties

1
  • filerCIK 0001405235

Filing Metadata

Form type
4
Filed
Dec 1, 7:00 PM ET
Accepted
Dec 2, 9:46 AM ET
Size
11.0 KB